drugset / Trial / NCT05527288
A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
NaSingle-groupOpen-labelDiagnostic
Summary
This is a bridging study to visually and quantitatively assess PET images obtained after single application of 300 MBq \[18F\]florbetaben and PET scanning of patients with Alzheimer disease.
Timeline
- Start
- 2021-01-28
- Primary completion
- 2021-09-12
- Completion
- 2021-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Florbetaben | Diagnostic / imaging agent | 300 mbq | Intravenous |